Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $10.7 million.

  • Inspire Medical Systems' Capital Expenditures rose 5164.37% to $10.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $38.5 million, marking a year-over-year decrease of 159.5%. This contributed to the annual value of $38.5 million for FY2025, which is 159.5% down from last year.
  • According to the latest figures from Q4 2025, Inspire Medical Systems' Capital Expenditures is $10.7 million, which was up 5164.37% from $10.4 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Capital Expenditures high stood at $12.4 million for Q2 2024, and its period low was $533000.0 during Q4 2021.
  • Over the past 5 years, Inspire Medical Systems' median Capital Expenditures value was $5.9 million (recorded in 2023), while the average stood at $5.8 million.
  • As far as peak fluctuations go, Inspire Medical Systems' Capital Expenditures surged by 45347.09% in 2022, and later crashed by 2812.07% in 2025.
  • Quarter analysis of 5 years shows Inspire Medical Systems' Capital Expenditures stood at $533000.0 in 2021, then surged by 453.47% to $2.9 million in 2022, then skyrocketed by 172.31% to $8.0 million in 2023, then fell by 12.52% to $7.0 million in 2024, then skyrocketed by 51.64% to $10.7 million in 2025.
  • Its Capital Expenditures was $10.7 million in Q4 2025, compared to $10.4 million in Q3 2025 and $9.0 million in Q2 2025.